Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for recovery after mastectomy
NCT05289440Completed
- Sponsor
- Anqing Municipal Hospital
- Start
- Mar 2022
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of esketamine in postoperative pain (3 arms), sponsored by Anqing Municipal Hospital. Primary endpoint: Quality of Recovery-15 at 1 day. Started Mar 2022; status: completed.
02
Drugs
esketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05289440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05289440.